Evaluation of the drug-drug interaction between low-dose methotrexate and short-term use of non-steroidal anti-inflammatory drugs

Expert Opinion on Drug Metabolism and Toxicology · Published 2025-08-08 · DOI 10.1080/17425255.2025.2546127

Authors being retrieved — see the publisher record. https://doi.org/10.1080/17425255.2025.2546127

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2025

Related articles

Tirabrutinib–anthracycline interactions in the brain tumor microenvironment: a focus on metabolic inactivation and resistance · Expert Opinion on Drug Metabolism and Toxicology · 2025 · Same journal
Microbiome-driven PKs: redefining drug metabolism beyond host enzymes · Expert Opinion on Drug Metabolism and Toxicology · 2026 · Same journal
Combined oral contraceptives and pharmacokinetic drug interactions: impact on efficacy and safety · Expert Opinion on Drug Metabolism and Toxicology · 2026 · Same journal
Predicting the potential for organic cation transporter 1-mediated drug–drug interactions with fenoterol by amitriptyline, fluoxetine, selegiline, metformin, and verapamil · Expert Opinion on Drug Metabolism and Toxicology · 2026 · Same journal
Pharmacokinetics and safety of the combination of KL130008 and methotrexate in rheumatoid arthritis patients: a multicenter, open-label phase Ib trial · Expert Opinion on Drug Metabolism and Toxicology · 2025 · Same journal
GLP-1RA PHARMACOKINETICS AND CLINICAL EFFECTS: FOCUS ON CARDIAC, VASCULAR, AND GLOMERULAR STRUCTURES · Expert Opinion on Drug Metabolism and Toxicology · 2026 · Same journal
Modifying Hy’s Law and eDISH for the modern idiosyncratic DILI era · Expert Opinion on Drug Metabolism and Toxicology · 2025 · Same journal
Exploring the influence of sex on idiosyncratic DILI: impact on risk assessment · Expert Opinion on Drug Metabolism and Toxicology · 2026 · Same journal
Complex in vitro model developers’ perspective on advanced hepatic in vitro culture methods for predictive drug safety · Expert Opinion on Drug Metabolism and Toxicology · 2026 · Same journal
An update on the pharmacokinetic and pharmacodynamic interactions between antidepressants and antiseizure medications · Expert Opinion on Drug Metabolism and Toxicology · 2026 · Same journal